Intech Biopharm Corporation

Total Valuation

Intech Biopharm Corporation carries a market capitalization of 2.47B, placing it among publicly traded companies globally. Its enterprise value stands at 3.63B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Intech Biopharm Corporation currently has 178.41M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 24.73, and the price-to-book ratio stands at 3.23.

Enterprise Valuation

Financial Position

Intech Biopharm Corporation maintains a current ratio of 1.66, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 107.96, indicating elevated leverage, while an interest coverage ratio of -10.87 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Intech Biopharm Corporation's stock has declined approximately -7.12251% over the past 52 weeks. The 50-day moving average sits at 16.10, while the 200-day moving average is 17.89.

Income Statement

Over the trailing twelve months, Intech Biopharm Corporation generated 107.53M in revenue and converted that into -389.03M in net income, yielding earnings per share of -2.60. EBITDA reached -364.50M, while operating income came in at -364.50M.

Balance Sheet

Intech Biopharm Corporation holds 214.30M in cash and equivalents against 1.19B in total debt, resulting in a net debt position of 1.17B. Total book value stands at 823.94M, with working capital of 159.81M providing operational flexibility.

Cash Flow

Intech Biopharm Corporation produced -361.13M in operating cash flow over the past twelve months. After subtracting -61.89M in capital expenditures, free cash flow totaled -423.02M - equivalent to -2.83 per share.

Margins

Intech Biopharm Corporation operates with a gross margin of -103.18, reflecting its pricing power and cost economics. The operating margin of -338.99 and net profit margin of -361.80 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Intech Biopharm Corporation's most recent stock split took place on September 26, 2023 with a 500:513 split ratio.

Scores

Intech Biopharm Corporation posts an Altman Z-Score of 0.32, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.